Tag: infectious diseases rapid diagnostic testing market
Recent content
-
Immunoassay Market on the Rise: Expected to Hit $49.6 Billion by 2027
Immunoassay Market is projected to grow from USD 40.2 billion in 2022 to USD 49.6 billion by 2027, at a CAGR of 4.3% from 2022 to 2027 -
Global Antimicrobial Susceptibility Testing Market to Exceed $4.7 Billion by 2027
Antimicrobial Susceptibility Testing Market in terms of revenue was estimated to be worth $3.6 billion in 2022 and is poised to reach $4.7 billion by 2027, growing at a CAGR of 5.5% from 2022 to 2027 -
Malaysia Clinical Labs Market is Expected to Reach More Than USD ~3000 Mn by 2027F Owing to Growing...
The Malaysia clinical labs market is fragmented with top players being BP Healthcare, Pantai, Premier, Pathology, and Innoquest Pathology. The value chain for independent lab chains in this industry has three core components: equipment...